Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Stockholders' Equity (Deficit)

v3.22.1
Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)
Total
IPO
Common Stock
Common Stock
IPO
Additional Paid-In Capital
Additional Paid-In Capital
IPO
Accumulated Deficit
Beginning balance at Dec. 31, 2019 $ (4,490,016)   $ 8,181   $ 7,685,533   $ (12,183,730)
Beginning balance, Shares at Dec. 31, 2019     8,180,937        
Stock-based compensation expense 573,695       573,695    
Issuance of warrants 1,443,426       1,443,426    
Issuance of common stock 4,870 $ 14,595,045 $ 15 $ 1,800 4,855 $ 14,593,245  
Issuance of common stock, Shares     14,175 1,800,000      
Conversion of notes 505,230   $ 55   505,175    
Conversion of notes, Shares     55,737        
Net loss (2,847,894)           (2,847,894)
Ending balance at Dec. 31, 2020 $ 9,784,356   $ 10,051   24,805,929   (15,031,624)
Ending balance, Shares at Dec. 31, 2020 10,050,849   10,050,849        
Stock-based compensation expense $ 1,531,876       1,531,876    
Issuance of warrants 688,784       688,784    
Issuance of common stock 60,391 $ 41,135,357 $ 9 $ 15,000 60,382 $ 41,120,357  
Issuance of common stock, Shares     9,000 15,000,000      
Issuance of common stock, stock options exercised 848   $ 95   753    
Issuance of common stock, stock options exercised, Shares     95,349        
Net loss (14,786,063)           (14,786,063)
Ending balance at Dec. 31, 2021 $ 38,415,549   $ 25,155   $ 68,208,081   $ (29,817,687)
Ending balance, Shares at Dec. 31, 2021 25,155,198   25,155,198